Tyra Biosciences, Inc. (TYRA)
Data as of , from SEC Form 4 filings.
Net insider buying (90d)Watch TYRA
See up to 3 months of TYRA. The 7-day demo opens the 1M and 3M ranges and puts TYRA on your watchlist.
Start 7-day demoLatest TYRA insider trades
- RA CAPITAL MANAGEMENT, L.P. - DirectorOpen-market purchase$199.99M
Rehan Verjee - DirectorOpen-market purchase$20K
About Tyra Biosciences, Inc. (TYRA)
The SEC lists Tyra Biosciences, Inc. under CIK 0001863127, in pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
TYRA Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 2 | 9,079,501 | $200.01M |
| Grant or award | 3 | 4,740 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
TYRA insider transactions (Form 4)
4649 Form 4 filings on record, the earliest from Oct 2, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Todd Harris - Officer | Grant or award | Common Stock | 864 | $9.13 | $8K | |
| Yuliya Rueb - Officer | Grant or award | Common Stock | 2,925 | $9.13 | $27K | |
| Alan Fuhrman - Officer | Grant or award | Common Stock | 951 | $9.13 | $9K | |
| RA CAPITAL MANAGEMENT, L.P. - Director | Open-market purchase | Pre-Funded Warrants (Right to Buy) | 9,078,529 | $22.03 | $199.99M | |
| Rehan Verjee - Director | Open-market purchase | Common Stock | 971.89 | $20.58 footnote F1 | $20K | |
| ||||||
| RA CAPITAL MANAGEMENT, L.P. | Grant or award | Stock Option (Right to Buy) | 13,160 | $0.00 | - | |
| Rehan Verjee | Grant or award | Stock Option (Right to Buy) | 13,160 | $0.00 | - | |
| Susan Moran | Grant or award | Stock Option (Right to Buy) | 13,160 | $0.00 | - | |
 Jake Simson | Grant or award | Stock Option (Right to Buy) | 13,160 | $0.00 | - | |
 Adele M. Gulfo | Grant or award | Stock Option (Right to Buy) | 13,160 | $0.00 | - | |
| Robert J. More | Grant or award | Stock Option (Right to Buy) | 13,160 | $0.00 | - | |
| Stephen Michael Rothenberg | Grant or award | Stock Option (Right to Buy) | 13,160 | $0.00 | - | |
| Douglas J. Warner - Officer | Grant or award | Common Stock | 25,000 footnote F1 | $0.00 | - | |
| Douglas J. Warner - Officer | Grant or award | Stock Option (Right to Buy) | 85,000 | $0.00 | - | |
| ||||||
| Alan Fuhrman - Officer | Grant or award | Common Stock | 20,000 footnote F1 | $0.00 | - | |
| Alan Fuhrman - Officer | Grant or award | Stock Option (Right to Buy) | 67,000 | $0.00 | - | |
| ||||||
| Todd Harris - Officer | Grant or award | Common Stock | 79,000 footnote F1 | $0.00 | - | |
| Todd Harris - Officer | Grant or award | Stock Option (Right to Buy) | 265,000 | $0.00 | - | |
| ||||||
| Bhavesh Ashar - Officer | Grant or award | Common Stock | 15,013 footnote F1 | $0.00 | - | |
| Bhavesh Ashar - Officer | Grant or award | Stock Option (Right to Buy) | 50,295 | $0.00 | - | |
| ||||||
| Yuliya Rueb - Officer | Grant or award | Common Stock | 8,333 footnote F1 | $0.00 | - | |
| Yuliya Rueb - Officer | Grant or award | Stock Option (Right to Buy) | 28,000 | $0.00 | - | |
| ||||||
| Habib J. Dable | Grant or award | Stock Option (Right to Buy) | 44,400 | $0.00 | - | |
| Gilla Kaplan | Option exercise | Common Stock | 14,295 | $2.25 | $32K | |
| Gilla Kaplan | Option exercise | Common Stock | 53,172 | $2.25 | $120K | |
| Gilla Kaplan | Open-market sale | Common Stock | 14,295 | $36.97 footnote F1 | $529K | |
| Gilla Kaplan | Derivative | Common Stock | 53,172 | $37.75 footnote F2 | $2.01M | |
| Gilla Kaplan | Option exercise | Stock Option (Right to Buy) | 14,295 | $0.00 | - | |
| Gilla Kaplan | Option exercise | Stock Option (Right to Buy) | 53,172 | $0.00 | - | |
| ||||||
| Alan Fuhrman - Officer | Grant or award | Common Stock | 1,376 | $9.13 | $13K | |
| Todd Harris - Officer | Grant or award | Common Stock | 1,463 | $9.13 | $13K | |
| Daniel Bensen - Officer | Open-market sale | Common Stock | 2,128 | $31.50 footnote F2 | $67K | |
| Daniel Bensen - Officer | Open-market sale | Common Stock | 5,872 | $33.37 footnote F3 | $196K | |
| ||||||
| Daniel Bensen - Officer | Open-market sale | Common Stock | 6,983 | $28.44 footnote F2 | $199K | |
| Daniel Bensen - Officer | Open-market sale | Common Stock | 1,017 | $29.08 footnote F3 | $30K | |
| ||||||
| Robert J. More | Open-market sale | Common Stock | 10,000 | $25.00 | $250K | |
| Daniel Bensen - Officer | Open-market sale | Common Stock | 8,000 | $22.64 footnote F2 | $181K | |
| ||||||
| Bhavesh Ashar - Officer | Grant or award | Stock Option (Right to Buy) | 300,000 | $0.00 | - | |
| Robert J. More | Open-market sale | Common Stock | 246,871 | $20.25 footnote F2 | $5.00M | |
| ||||||
| Daniel Bensen - Officer | Open-market sale | Common Stock | 75,633 | $16.07 footnote F2 | $1.22M | |
| Daniel Bensen - Officer | Open-market sale | Common Stock | 49,956 | $16.32 footnote F3 | $815K | |
| ||||||
| Daniel Bensen - Officer | Open-market sale | Common Stock | 1,500 | $17.07 footnote F5 | $26K | |
| Daniel Bensen - Officer | Open-market sale | Common Stock | 1,111 | $16.00 footnote F2 | $18K | |
| Daniel Bensen - Officer | Open-market sale | Common Stock | 110,228 | $16.02 footnote F3 | $1.77M | |
| Daniel Bensen - Officer | Open-market sale | Common Stock | 18,572 | $16.11 footnote F4 | $299K | |
| ||||||
| Alan Fuhrman - Officer | Grant or award | Common Stock | 701 | $9.13 | $6K | |
Item 8.01, 9.01
Item 8.01
Item 2.02, 9.01
Item 5.07
Recent TYRA Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - |
TYRA insider trading FAQ
What is the latest insider trade for TYRA?
Tyra Biosciences, Inc. (TYRA) had 5 insider filings in the last 90 days, with the most recent on 2026-09-17. The full record for TYRA runs to 49 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying TYRA stock?
2 insider purchases of TYRA were filed in the last 90 days, totaling $200.01M.
How many insiders are selling TYRA stock?
No insider sales of TYRA were filed in the last 90 days. 47 sales are on record for this company.
Where can I see TYRA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects TYRA Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Todd Harris view on EDGAR
- - Yuliya Rueb view on EDGAR
- - Alan Fuhrman view on EDGAR
- - RA CAPITAL MANAGEMENT, L.P. view on EDGAR
- - Rehan Verjee view on EDGAR
- - RA CAPITAL MANAGEMENT, L.P. view on EDGAR
- - Rehan Verjee view on EDGAR
- - Susan Moran view on EDGAR
- - Jake Simson view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where TYRA's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow TYRA with a 7-day demo
- TYRA on your watchlist
- Every TYRA Form 4 filing on record
- Up to 3 months of TYRA price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
